ATE477798T1 - Verwendung von agomelatin zur herstellung von medikamenten zur behandlung der generalisierten angststörung - Google Patents

Verwendung von agomelatin zur herstellung von medikamenten zur behandlung der generalisierten angststörung

Info

Publication number
ATE477798T1
ATE477798T1 AT07290420T AT07290420T ATE477798T1 AT E477798 T1 ATE477798 T1 AT E477798T1 AT 07290420 T AT07290420 T AT 07290420T AT 07290420 T AT07290420 T AT 07290420T AT E477798 T1 ATE477798 T1 AT E477798T1
Authority
AT
Austria
Prior art keywords
agomelatin
medications
treatment
production
anxiety disorder
Prior art date
Application number
AT07290420T
Other languages
English (en)
Inventor
Bruno Delalleau
Agnes Fabiano
Mark Millan
Elisabeth Mocaer
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37308935&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE477798(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of ATE477798T1 publication Critical patent/ATE477798T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT07290420T 2006-04-07 2007-04-06 Verwendung von agomelatin zur herstellung von medikamenten zur behandlung der generalisierten angststörung ATE477798T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0603083A FR2899472B1 (fr) 2006-04-07 2006-04-07 Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement du trouble anxiete generalisee

Publications (1)

Publication Number Publication Date
ATE477798T1 true ATE477798T1 (de) 2010-09-15

Family

ID=37308935

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07290420T ATE477798T1 (de) 2006-04-07 2007-04-06 Verwendung von agomelatin zur herstellung von medikamenten zur behandlung der generalisierten angststörung

Country Status (43)

Country Link
US (1) US7960438B2 (de)
EP (1) EP1842535B1 (de)
JP (1) JP4880031B2 (de)
KR (1) KR20070100657A (de)
CN (1) CN101049290B (de)
AP (1) AP2488A (de)
AR (1) AR060349A1 (de)
AT (1) ATE477798T1 (de)
AU (1) AU2007201527B2 (de)
BR (1) BRPI0701601A (de)
CA (1) CA2584060C (de)
CO (1) CO5840252A1 (de)
CR (1) CR9019A (de)
CY (1) CY1111287T1 (de)
DE (1) DE602007008494D1 (de)
DK (1) DK1842535T3 (de)
EA (1) EA012608B1 (de)
ES (1) ES2351062T3 (de)
FR (1) FR2899472B1 (de)
GE (1) GEP20094743B (de)
GT (1) GT200700032A (de)
HR (1) HRP20100577T1 (de)
IL (1) IL182407A (de)
JO (1) JO3440B1 (de)
MA (1) MA28987B1 (de)
ME (1) ME01865B (de)
MX (1) MX2007004100A (de)
MY (1) MY143269A (de)
NI (1) NI200700084A (de)
NO (1) NO20071774L (de)
NZ (1) NZ554347A (de)
PE (1) PE20080174A1 (de)
PL (1) PL1842535T3 (de)
PT (1) PT1842535E (de)
RS (1) RS51485B (de)
SA (1) SA07280161B1 (de)
SG (1) SG136881A1 (de)
SI (1) SI1842535T1 (de)
TN (1) TNSN07118A1 (de)
TW (1) TWI374736B (de)
UY (1) UY30262A1 (de)
WO (1) WO2007116136A1 (de)
ZA (1) ZA200702865B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101481321B (zh) * 2009-02-27 2012-04-18 上海医药工业研究院 阿戈美拉汀卤化氢复合物及其制备方法
CN101585779B (zh) * 2009-03-10 2014-04-02 上海医药工业研究院 阿戈美拉汀的晶型vi及其制备方法和应用
FR2956031B1 (fr) * 2010-02-11 2012-03-02 Servier Lab Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement du trouble obsessionnel compulsif (toc)
CN102190595A (zh) * 2010-03-17 2011-09-21 上海医药工业研究院 阿戈美拉汀溴化氢水合物及其制备方法
CN102190594A (zh) * 2010-03-17 2011-09-21 上海医药工业研究院 阿戈美拉汀氯化氢水合物及其制备方法
PH12012000132B1 (en) * 2011-06-09 2014-10-20 Servier Lab New co-crystals of agomelatine, a process for their preparation and pharmaceutical compositions containing them
FR2978916B1 (fr) * 2011-08-10 2013-07-26 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
HUE036989T2 (hu) 2013-06-06 2018-08-28 Zentiva Ks Agomelatin készítmény, amely agomelatint ko-kristály formájában tartalmaz
EP2810647A1 (de) 2013-06-06 2014-12-10 Zentiva, a.s. Pharmazeutische Formulierungen, enthaltend Agomelatin in der Form des Co-Kristalls von Agomelatin mit organischer Säure
IT201900002913A1 (it) 2019-03-01 2020-09-01 Nicola Pescosolido Composto utile per il trattamento del glaucoma
CN110867197A (zh) * 2019-10-23 2020-03-06 吴杰 语音交互过程中实时打断语音机器人的方法及设备
CN116785225A (zh) * 2022-03-15 2023-09-22 湖南慧泽生物医药科技有限公司 阿戈美拉汀鼻部制剂
CN118021721A (zh) * 2024-01-19 2024-05-14 沈阳药科大学 一种脑靶向阿戈美拉汀鼻喷胶束的制备方法与应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
SG45100A1 (en) * 1994-03-07 1998-01-16 Ibm Improvements in image processing
DE19532842C1 (de) * 1995-09-05 1996-12-19 Ibm Bildaufnahmesystem
AR047553A1 (es) * 2003-07-04 2006-01-25 Lundbeck & Co As H La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina
JP2007517040A (ja) * 2003-12-24 2007-06-28 セプレイコー インコーポレイテッド 睡眠の質を改善するためのメラトニン併用療法
FR2866335B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine
US20060199805A1 (en) * 2005-03-04 2006-09-07 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
US7635721B2 (en) * 2005-08-03 2009-12-22 Les Laboratoires Servier Crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it
US7358395B2 (en) * 2005-08-03 2008-04-15 Les Laboratories Servier Crystalline form V of agomelatine, a process for its preparation and pharmaceutical compositions containing it
TW200735878A (en) * 2005-11-18 2007-10-01 Astrazeneca Ab Pharmaceutical compositions

Also Published As

Publication number Publication date
CN101049290A (zh) 2007-10-10
EP1842535B1 (de) 2010-08-18
MX2007004100A (es) 2009-02-16
BRPI0701601A (pt) 2007-12-11
RS51485B (sr) 2011-04-30
GT200700032A (es) 2007-10-31
CA2584060C (fr) 2011-04-26
SG136881A1 (en) 2007-11-29
FR2899472B1 (fr) 2008-09-12
PT1842535E (pt) 2010-09-28
MA28987B1 (fr) 2007-11-01
HRP20100577T1 (hr) 2010-11-30
PE20080174A1 (es) 2008-03-29
JP4880031B2 (ja) 2012-02-22
TW200808295A (en) 2008-02-16
FR2899472A1 (fr) 2007-10-12
PL1842535T3 (pl) 2011-01-31
EP1842535A1 (de) 2007-10-10
EA012608B1 (ru) 2009-10-30
HK1108367A1 (en) 2008-05-09
NO20071774L (no) 2007-10-08
CY1111287T1 (el) 2015-08-05
DE602007008494D1 (de) 2010-09-30
CN101049290B (zh) 2012-10-31
ME01865B (me) 2011-04-30
JO3440B1 (ar) 2019-10-20
EA200700574A3 (ru) 2007-12-28
CA2584060A1 (fr) 2007-10-07
EA200700574A2 (ru) 2007-10-26
NZ554347A (en) 2008-08-29
SA07280161B1 (ar) 2010-10-23
GEP20094743B (en) 2009-07-27
UY30262A1 (es) 2007-05-31
TWI374736B (en) 2012-10-21
IL182407A (en) 2016-02-29
SI1842535T1 (sl) 2010-10-29
US20070238792A1 (en) 2007-10-11
MY143269A (en) 2011-04-15
CO5840252A1 (es) 2007-12-31
AU2007201527A1 (en) 2007-10-25
TNSN07118A1 (fr) 2008-06-02
JP2009532446A (ja) 2009-09-10
IL182407A0 (en) 2008-01-20
AR060349A1 (es) 2008-06-11
DK1842535T3 (da) 2010-11-15
AP2488A (en) 2012-10-03
WO2007116136A1 (fr) 2007-10-18
US7960438B2 (en) 2011-06-14
ES2351062T3 (es) 2011-01-31
CR9019A (es) 2008-10-28
NI200700084A (es) 2008-04-24
KR20070100657A (ko) 2007-10-11
AU2007201527B2 (en) 2012-08-09
ZA200702865B (en) 2008-07-30
AP2007003953A0 (en) 2007-04-30

Similar Documents

Publication Publication Date Title
ATE477798T1 (de) Verwendung von agomelatin zur herstellung von medikamenten zur behandlung der generalisierten angststörung
EP2076326A4 (de) Ce-zr-r-o-katalysatoren, artikel mit den ce-zr-r-o-katalysatoren sowie verfahren zur herstellung und verwendung der ce-zr-r-o-katalysatoren
EP3861968C0 (de) Vorrichtungen zur behandlung von schlafapnoe
EP2118940A4 (de) Vorrichtung zur kontinuierlichen herstellung von supraleitenden bändern
DE602007013512D1 (de) Verfahren zur kontinuierlichen Herstellung von Bauteilen
EP3620465C0 (de) Verbesserte verfahren zur herstellung, markierung und verwendung von mhc-multimeren
EP1981526A4 (de) Adiponectin zur behandlung verschiedener erkrankungen
ATE434620T1 (de) Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
ATE512661T1 (de) Verwendung eines betablockers zur herstellung eines arzneimittels zur behandlung von hämangiomen
EP1758597A4 (de) Verwendung von arzneimittelkombinationen zur behandlung der insulinresistenz
DE112007001307A5 (de) Mikrobiologische Herstellung von 3-Hydroxyisobuttersäure
DE602007007146D1 (de) Verfahren zur Herstellung von Müsliriegeln mit verbesserter Konsistenz
ATE550329T1 (de) Heterobicyclische sulfonamidderivate zur behandlung von diabetes
EP4091585C0 (de) Vorrichtung zur behandlung von refluxösophagitis
EP2366794A4 (de) Verfahren zur herstellung von poly-3-hydroxyalkanoat und poly-3-hydroxyalkanoatagglomerat
EP3821910C0 (de) Oligosaccharid und verfahren zur herstellung davon
DE502008000313D1 (de) Verfahren zur kontinuierlichen Herstellung von Aminoalkylgruppen aufweisenden Organopolysiloxanen
DE112008000701A5 (de) Zusammensetzung zur Herstellung von Speisern
EP2257516A4 (de) Verfahren zur herstellung von cyclododecatrien und verfahren zur herstellung von laurolacton
PL2307000T3 (pl) Połączenie pilokarpiny i metimazolu do leczenia choroby Charcota-Mariegotootha i pokrewnych zaburzeń
EP2014783A4 (de) Verfahren zur herstellung von feuerverzinktem stahlblech und feuerverzinktes stahlblech
ATE521365T1 (de) Kinin-antagonisten zur behandlung von blasenfunktionsstörung
EP2249765A4 (de) Dapson zur behandlung von rosascea
PL2330892T3 (pl) Sposoby leczenia z zastosowaniem leków wychwytujących amoniak
EP2259269A4 (de) Verfahren zur herstellung von radiostrontium

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1842535

Country of ref document: EP